47th Annual Carrell Krusen Neuromuscular Symposium (RP2502C)
This symposium is a clinical education experience for members of multidisciplinary teams who care for patients with rare, complex neuromuscular diseases including hereditary muscular dystrophies, motor neuron diseases, neuroimmunologic neuropathies and rare genetic disorders of muscle and nerve. Case presentations will include physical diagnosis and discussion of management and new therapies by participating experts. All discussions involve active participation by attendees. The educational format for this activity includes didactic lectures with in depth Q&A, panel discussions, and PowerPoint Presentations. The content of the program is identified and developed through a Call for Abstracts process. The 2025 keynote speaker will present a formal lecture on congenital myopathies, a group of ultra-rare, single gene disorders that he has studied for 3 decades. He has been a leader in gene discovery for these disorders and a pioneer in developing therapies.
HOW DO I REGISTER?
Click on the "REGISTER" tab, choose the appropriate category, and pay the registration fee
Registration Type | Before 1/10/25 | After 1/10/25 |
Physicians (MD/DO) | $200 | $250 |
Advanced Practice Providers (PAs/NPs) | $150 | $200 |
Other Healthcare Professionals (OT/PT/SPL) | $150 | $200 |
Trainees (Fellows/Residents/Medical Students) | $50 | $75 |
Nurses | $50 | $75 |
Research Coordinators | $100 | $125 |
Exhibit/Industry Representative | $275 | $325 |
Submit an Abstract
Help shape this year's conference by submitting an abstract! Open to all members of the interdisciplinary team.
Click HERE to submit an abstract!
The deadline for abstract submission is Friday, November 22, 2024.
Target Audience
This program is specifically designed for Primary Care providers, Neurologists, Nurses, Advanced Practitioners, and Researchers that desire to gain advanced knowledge in diagnosis and management of patients with neuromuscular disease.
Learning Objectives
- Discuss genotype/phenotype correlation for the congenital myopathies. Review results of clinical trials and plans for upcoming trials. Review management aimed at quality of life.
- Discuss recent advances in the genetic diagnosis of neuromuscular disorders, in research and clinical practice and the latest developments in treatment such as gene replacement therapy, cell therapy and forms of RNA therapy.
- Identify and apply current pharmacological and non-pharmacological treatments in motor neuron diseases including gene replacement therapy.
- Recognize the clinical applications of results of imaging both MRI and ultrasound as well as histopathology in neuromuscular disorders.
Travel
Hotel Room Block details coming soon!
Salman Bhai, MD
Zurisadai Gonzalez Castillo, MD
Anne Marie Jones, MS, BSN, RN
Lauren Phillips, MD
Jaya Trivedi, MD, FAAN, FANA
Steven Vernino, MD, PhD, FAAN, FANA, FAAS
Kaitlin Batley, MD
Susan Iannaccone, MD
Shaida Khan, D.O.
George Bailey
Erica Knoll, MPAS, PA-C
Sharon Nations
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Texas Southwestern Medical Center designates this live activity for a maximum of 9.75 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 9.75 AMA
- 9.75 Attendance